SPONSOR
Beijing Biotech
Total Trials
10
Recruiting
10
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: Malignant Pleural MesotheliomasNon-Small Cell Lung CancerAdvanced/Metastatic NSCLCAdvanced Solid TumorsMetastatic Solid TumorsTROP2-Expressing Solid TumorsColorectal CancerMetastatic Colorectal AdenocarcinomaUnresectable Colorectal CancerMetastatic Castration-resistant Prostate Cancer
Beijing Biotech is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Malignant Pleural Mesotheliomas, Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC, Advanced Solid Tumors.
The trial portfolio spans Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing Biotech
How many clinical trials has Beijing Biotech sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Beijing Biotech, of which 10 are actively recruiting participants. These trials cover conditions including Malignant Pleural Mesotheliomas, Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing Biotech research focus on?
Beijing Biotech clinical trials span Malignant Pleural Mesotheliomas, Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC, Advanced Solid Tumors, Metastatic Solid Tumors, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Beijing Biotech clinical trial?
To participate in a Beijing Biotech trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing Biotech trials with current recruitment status updated daily.
Clinical Trials by Beijing Biotech
NCT07510815 Phase 1, Phase 2
Recruiting
Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Malignant Pleural Mesotheliomas
NCT07467863 Phase 1, Phase 2
Recruiting
Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC
Non-Small Cell Lung Cancer
NCT07589530 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors
Advanced Solid Tumors
NCT07589517 Phase 1, Phase 2
Recruiting
Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer
Colorectal Cancer
NCT07641049 Phase 1
Recruiting
Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
NCT07486089 Phase 1, Phase 2
Recruiting
Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)
Breast Cancer (Locally Advanced or Metastatic)
NCT07510802 Phase 1, Phase 2
Recruiting
Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC
Breast Cancer (Advanced/Metastatic)
NCT07551336 Phase 1
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Malignant Glioma
NCT07617753 Phase 1, Phase 2
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2
Epithelial Ovarian Cancer
NCT07551349 Phase 1, Phase 2
Recruiting
Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma
Advanced or Metastatic Clear Cell Renal Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology